|
|
Volumn 10, Issue 18, 2005, Pages 1216-1218
|
|
Evolution of biomarkers: Drug discovery to personalized medicine
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BIOLOGICAL MARKER;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
GLUCURONOSYLTRANSFERASE 1A1;
IRINOTECAN;
MESSENGER RNA;
MONOCLONAL ANTIBODY;
PROTEIN;
TRASTUZUMAB;
BLOOD BRAIN BARRIER;
BREAST CANCER;
CANCER;
CANCER CHEMOTHERAPY;
CENTRAL NERVOUS SYSTEM;
CENTRAL NERVOUS SYSTEM DISEASE;
CEREBROSPINAL FLUID;
CONFERENCE PAPER;
COST;
DIARRHEA;
DRUG EFFICACY;
DRUG INDUSTRY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
GENOTYPE;
HUMAN;
IMAGING;
IMMUNOASSAY;
INFLAMMATORY DISEASE;
LEUKOPENIA;
LIVER INJURY;
MASS SPECTROMETRY;
MEDICAL RESEARCH;
METABOLOMICS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
PATHOGENESIS;
PATHOPHYSIOLOGY;
PHARMACOGENOMICS;
POLYMERASE CHAIN REACTION;
POSITRON EMISSION TOMOGRAPHY;
PREDICTION;
PROTEIN EXPRESSION;
PROTEOMICS;
RHEUMATOID ARTHRITIS;
SINGLE NUCLEOTIDE POLYMORPHISM;
BIOLOGICAL MARKERS;
DRUG DESIGN;
HUMANS;
PHARMACOGENETICS;
|
|
EID: 26244435220
PISSN: 13596446
EISSN: None
Source Type: Journal
DOI: 10.1016/S1359-6446(05)03591-9 Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (5)
|
